Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bachmann

Showing results (501-510 of 577) with videos related to

Pageof 58
Sort By:
Molecular Immunology|March 29, 2008
Identification of Ly-6K as a novel marker for mouse plasma cellsCaroline E von Allmen, Monika Bauer, Klaus Dietmeier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2010
A virus-like particle-based anti-nerve growth factor vaccine reduces inflammatory hyperalgesia: potential long-term therapy for chronic painTill A Röhn, William T Ralvenius, Jolly Paul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1Carsten Gründemann, Monika Bauer, Oliver Schweier, et al.
Frontiers in Immunology|February 7, 2022
TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle ImmunizationXinyue Chang, Pascal Krenger, Caroline C Krueger, et al.
Immunity|March 1, 2011
Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center responseBaidong Hou, Philippe Saudan, Gary Ott, et al.
Annals of the Rheumatic Diseases|March 14, 2019
Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritisIsabell S von Loga, Aadil El-Turabi, Luke Jostins, et al.
Scientific Reports|June 21, 2017
Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccinesDarren B Leneghan, Kazutoyo Miura, Iona J Taylor, et al.
Vaccines|August 29, 2024
Green Routes: Exploring Protein-Based Virus-like Nanoparticle Transport and Immune Activation in <i>Nicotiana benthamiana</i> for Biotechnological ApplicationsRomano Josi, Alessandro Pardini, Alexander Haindrich, et al.
The Journal of Experimental Medicine|December 8, 1998
Vav regulates peptide-specific apoptosis in thymocytesY Y Kong, K D Fischer, M F Bachmann, et al.
The Journal of Allergy and Clinical Immunology|February 7, 2013
The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthmaKai-Michael Beeh, Frank Kanniess, Frank Wagner, et al.
Pageof 58

Showing results (501-510 of 577) with videos related to

Sort By:
Pageof 58
Molecular Immunology|March 29, 2008
Identification of Ly-6K as a novel marker for mouse plasma cellsCaroline E von Allmen, Monika Bauer, Klaus Dietmeier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2010
A virus-like particle-based anti-nerve growth factor vaccine reduces inflammatory hyperalgesia: potential long-term therapy for chronic painTill A Röhn, William T Ralvenius, Jolly Paul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1Carsten Gründemann, Monika Bauer, Oliver Schweier, et al.
Frontiers in Immunology|February 7, 2022
TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle ImmunizationXinyue Chang, Pascal Krenger, Caroline C Krueger, et al.
Immunity|March 1, 2011
Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center responseBaidong Hou, Philippe Saudan, Gary Ott, et al.
Annals of the Rheumatic Diseases|March 14, 2019
Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritisIsabell S von Loga, Aadil El-Turabi, Luke Jostins, et al.
Scientific Reports|June 21, 2017
Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccinesDarren B Leneghan, Kazutoyo Miura, Iona J Taylor, et al.
Vaccines|August 29, 2024
Green Routes: Exploring Protein-Based Virus-like Nanoparticle Transport and Immune Activation in <i>Nicotiana benthamiana</i> for Biotechnological ApplicationsRomano Josi, Alessandro Pardini, Alexander Haindrich, et al.
The Journal of Experimental Medicine|December 8, 1998
Vav regulates peptide-specific apoptosis in thymocytesY Y Kong, K D Fischer, M F Bachmann, et al.
The Journal of Allergy and Clinical Immunology|February 7, 2013
The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthmaKai-Michael Beeh, Frank Kanniess, Frank Wagner, et al.
Pageof 58